🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Susan Soto

National Institutes of Health

ORCID: 0009-0003-3746-890X

Also affiliated with National Heart Lung and Blood Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines”.

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Blood(2020)10.1182/blood.2020008758
N/A
7.9DataRank · unranked
141 citations

Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn +9 more

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3217
N/A
0.782DataRank · unranked
21 citations

Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian +12 more

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Blood Advances(2022)10.1182/bloodadvances.2021006574
N/A
0.510DataRank · unranked
29 citations

Kerry J. Laing, Mir A. Ali, Christopher L. McClurkan, Susan Soto, Inhye E. Ahn +10 more

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379
N/A
0.286DataRank · unranked
4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1772477
N/A
0DataRank · unranked
27 citations

Clare Sun, Sanjal H. Desai, Inhye E. Ahn, Xin Tian, Pia Nierman +6 more

A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia

American Journal of Hematology(2020)10.1002/ajh.25968
N/A
0DataRank · unranked
5 citations

Xin Tian, Shakuntala Rampertaap, Rui Mu, Susan Soto, Jeanine Superata +12 more